Rovelo LJE, Rodríguez WU, Badillo BA, Meza SJC

Idioma: Español
Referencias bibliográficas: 22
Paginas: 20-23
Archivo PDF: 45.92 Kb.

RESUMEN

El cáncer colorrectal es una neoplasia prevenible e idónea para el escrutinio, dado el conocimiento de la progresión de adenoma a carcinoma; el 70% son pacientes de riesgo promedio y el 30% tienen un componente hereditario o enfermedad inflamatoria intestinal que los hace de alto riesgo. Se recomienda a partir de los 50 años iniciar el escrutinio por los médicos de primer contacto en pacientes promedio con uno o varios de los siguientes métodos, búsqueda de sangre oculta en heces, sigmoidoscopia flexible, enema de doble contraste, colonoscopia virtual, y/o colonoscopia con toma de biopsia y/o polipectomía, para referir de manera oportuna al especialista. En pacientes de alto riesgo se cuenta ya con pruebas moleculares para búsqueda de mutaciones genéticas específicas, junto con los métodos antes mencionados.

REFERENCIAS (EN ESTE ARTÍCULO)

1. Mandel JS. Screening of patients at average risk for colon cancer. Med Clin N Am 2005; 89: 43-59.

2. Brosseuk D. Initial experience with a general population colorectal cancer screening clinic. Am J Surg 2006; 191: 669-672.

3. Maciosek MV. Colorectal cancer screening. Health impact and cost effectiveness. Am J Prev Med 2006; 31(1): 80-89.

4. Ladabaum U. Colorectal cancer screening. Differential costs for younger versus older Americans. Am J Prev Med 2006; 30(5): 378-384.

5. Lafata JE. Patient-Physician colorectal cancer screening discussions and screening use. Am J Prev Med 2006; 31(3): 202-209.

6. Lieberman D. Screening for colorectal cancer in average-risk populations. Am J Med 2006; 119: 728-735.

7. Trowbridge B. Colorectal cancer screening. Surg Clin N Am 2002; 82: 943-957.

8. Wei JT. The right test for colon cancer screening? Gastrointest Endosc 2006; 63(3): 459-460.

9. Walter LC. Screening for colorectal, breast, and cervical cancer in the elderly: A review of the evidence. Am J Med 2005; 118: 1078-1086.

10. Gilbert A, Kanarek N. Colorectal cancer screening: Physician recommendation is influential advice to Marylanders. Prev Med 2005; 41: 367-379.

11. Davila RE et al. ASGE guideline: the role of endoscopy in the diagnosis, staging, and management of colorectal cancer. Gastrointest Endosc 2005; 61: 1-7.

12. Ransohoff D. Colon cancer screening in 2005 status and challenges. Gastroenterology 2005; 128: 1685-1695.

13. Banerjee S. CT colonography for colon cancer screening. Gastrointest Endosc 2006; 63: 121-133.

14. Yee J. Screening CT colonography. Radiol Clin N Am 2004; 42: 757-766.

15. Burt R. Genetic testing for inherited colon cancer. Gastroenterology 2005; 128: 1696-1716.

16. ASGE. ASGE guideline: colorectal cancer screening and surveillance. Gastrointest Endosc 2006; 63: 546-557.

17. Bosworth HB et al. Prospective comparison of patient experience with colon imaging tests. Am J Med 2006; 19: 791-799.

18. Robertson RH et al. Trends in colon cancer screening procedures in the US Medicare and Tricare populations: 1999-2001. Prev Med 2006; 42: 460-462.

19. Federici A et al. Colorectal cancer screening: recommendations and guideline adherence by physicians from digestive endoscopy centers in the Lazio region, Italy. Prev Med 2006; 43: 183-186.

20. Walsh JME. Colon cancer screening in the ambulatory setting. Prev Med 2002; 35: 209-218.

21. Wee CC et al. Factors associated with colon cancer screening: the role of patient factors and physician counseling. Prev Med 2005; 41: 23-29.

22. Yepes-Rios M et al. Colorectal cancer screening among Mexican americans at a community clinic. Am J Prev Med 2006; 30: 204-210.